# REPATHA
> **BLA125522** · Biologics License Application · Sponsor: AMGEN INC · Approved 2021-02-26
## Drug
- **FDA Application Number:** BLA125522
- **Application type:** Biologics License Application
- **Brand name:** REPATHA
- **Generic name:** EVOLOCUMAB
- **Active ingredients:** EVOLOCUMAB
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** AMGEN INC
- **Manufacturer:** Amgen USA Inc.
- **First approval:** 2021-02-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125522)
---
*AI Analytics · CC0 1.0*